Anterogen안트로젠
065660 · KOSDAQ · ₩065660 · 안트로젠
₩13,360▼ ₩720 (5.11%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | ₩7.5B | ₩6.9B | ₩6.5B | ₩6.6B | ₩8.1B |
| Cost of sales | ₩4.9B | ₩4.3B | ₩3.8B | ₩4B | ₩4.2B |
| Gross profit | ₩2.7B | ₩2.6B | ₩2.7B | ₩2.6B | ₩3.9B |
| Operating income | −₩2.4B | −₩3.7B | −₩5.1B | −₩4.6B | −₩2.6B |
| Net income | −₩1.4B | −₩2.3B | −₩2.8B | −₩6.8B | −₩554M |
| Net income to shareholders | −₩1.4B | −₩2.3B | −₩2.8B | −₩6.8B | −₩554M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Total assets | ₩88B | ₩116B | ₩149B | ₩124B | ₩137B |
| Current assets | ₩48B | ₩45B | ₩56B | ₩62B | ₩65B |
| Cash and equivalents | ₩1.6B | ₩1.5B | ₩1.4B | ₩3.9B | ₩7B |
| Total liabilities | ₩813M | ₩5.9B | ₩20B | ₩17B | ₩20B |
| Current liabilities | ₩618M | ₩1.5B | ₩11B | ₩15B | ₩14B |
| Borrowings | — | — | ₩9.7B | ₩13B | ₩12B |
| Total equity | ₩87B | ₩110B | ₩129B | ₩107B | ₩117B |
| Shareholders' equity | ₩87B | ₩110B | ₩129B | ₩107B | ₩117B |
Cash flow
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash from operations | −₩1B | −₩860M | −₩2B | −₩2B | −₩3B |
| Capital spending | ₩98M | ₩181M | ₩150M | ₩1.5B | ₩3.3B |
| Free cash flow | −₩1.1B | −₩1B | −₩2.1B | −₩3.4B | −₩6.4B |
Consolidated where available. Amounts in won.
Also known as: Anterogen / 안트로젠 / 065660 / KRX:065660
Source: KRX statistical information